Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Bayer AG    BAYN   DE000BAY0017

BAYER AG (BAYN)

Real-time Quote. Real-time Tradegate - 01/24 10:00:35 pm
101.581 EUR   +0.53%
01/18DJBayer Joins Jobs Parade -- WSJ
01/18DJBAYER : Will Keep Monsanto Jobs in U.S., Trump Team Says -- 2nd Upda..
01/17DJBAYER : Will Keep Monsanto Jobs in U.S., Trump Team Says -- Update
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Bayer Stops Sale of Glucose Meter Business

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/09/2013 | 12:07pm CET

By Hendrik Varnholt

FRANKFURT--German pharmaceutical company Bayer AG (>> Bayer AG) will retain its blood glucose meter business, a spokeswoman said Wednesday, confirming a Bloomberg report.

Bayer had put up the unit for sale and had been in talks with French peer Sanofi SA (>> SANOFI) about a deal which could have been valued at around $1.5 billion, people familiar with the matter told Dow Jones Newswires in December.

"We have evaluated several options and decided to retain it," Bayer HealthCare chief Joerg Reinhardt said about the glucose meter business, according to Bloomberg.

Natali Schwab, Eyk Henning and Dana Cimilluca contributed to this story.

Write to Hendrik Varnholt at hendrik.varnholt@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Stocks mentioned in the article : Bayer AG, SANOFI
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BAYER AG
01/18DJBayer Joins Jobs Parade -- WSJ
01/18DJBAYER : Will Keep Monsanto Jobs in U.S., Trump Team Says -- 2nd Update
01/17DJBAYER : Will Keep Monsanto Jobs in U.S., Trump Team Says -- Update
01/17DJBAYER : Will Keep Monsanto Jobs in U.S., Trump Team Says
01/12 BAYER : Regorafenib from Bayer Granted Priority Review in the U.S. for Second-Li..
01/12 Bayer says had productive meeting with Trump over Monsanto deal
01/12 BAYER : CEOs of Monsanto and Bayer meet with Trump, press case for merger
01/11DJBAYER : Monsanto CEOs Pitch Deal to Trump
01/10 BAYER : MILITARY $6,894 Federal Contract Awarded to Bayer HealthCare
01/09 BAYER : Volker Koch-Achelpöhler to head Bayer’s EU Liaison Office in Bruss..
More news
Sector news : Pharmaceuticals - NEC
08:54pDJMARKET SNAPSHOT : Dow Makes A Run At Elusive 20,000 Amid Earnings Fusillade
07:24p MORGAN STANLEY : Toronto biotech raises $200 million ahead of ADHD drug decision
01:30pDJJOHNSON & JOHNSON : Revenue Rises But Forecast Disappoints
12:35a U.S. reaches settlement with Endo on pay-for-delay charges
01/20 European shares ease ahead of Trump inauguration
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
01/23 Roche Challenges Keytruda's Colorectal Cancer Pole Position
01/23 Bristol Looks To Exploit Opdivo's Liver Cancer Advantage
01/18 Xbiotech Has A Great Upside Potential With Only Limited Downside After Reveal..
01/18 Bayer Has Little Upside Left
01/18 Vet med industry now dominated by four firms; further mergers unlikely
Advertisement
Financials (€)
Sales 2016 46 742 M
EBIT 2016 8 709 M
Net income 2016 4 762 M
Debt 2016 15 663 M
Yield 2016 2,66%
P/E ratio 2016 17,42
P/E ratio 2017 15,56
EV / Sales 2016 2,12x
EV / Sales 2017 1,96x
Capitalization 83 563 M
More Financials
Chart BAYER AG
Duration : Period :
Bayer AG Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders
Full-screen chart
Technical analysis trends BAYER AG
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Average target price 109 €
Spread / Average Target 7,6%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Werner Baumann Chairman-Management Board
Werner Wenning Chairman-Supervisory Board
Johannes M. Dietsch Chief Financial Officer
Katharina Jansen Head-Science & Research
Hartmut Klusik Human Resources, Technology & Sustainability
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
BAYER AG3.40%89 744
JOHNSON & JOHNSON-1.13%309 896
ROCHE HOLDING LTD.0.39%200 025
PFIZER INC.-3.14%190 910
NOVARTIS AG-4.32%183 809
MERCK & CO., INC.4.99%170 419
More Results